Psychological Morbidity in patients with Idiopathic Hirsutism presenting for Laser Treatment at a Tertiary Care Hospital by Naheed, Aqsa et al.
345                                                                             Journal of Rawalpindi Medical College (JRMC); 2021; 25(3): 345-350 
Original Article 
 
Psychological Morbidity in patients with Idiopathic 
Hirsutism presenting for Laser Treatment at a 
Tertiary Care Hospital  
Aqsa Naheed1, Aalia Akhtar Hayat2, Qurat ul Ain3, Bushra Razzaque4, Sundus Fatima5, Nasser Dar6  
1 Associate Professor, Department of Dermatology, 
HITEC-Institute of Medical Sciences, Taxila.  
2 Consultant Psychiatrist, Maternity and Children 
Hospital, Makka al Mukarama.  
3 Assistant Professor, Department of Psychiatry, 
Benazir Bhutto Hospital, Rawalpindi.  
4 Senior Registrar, Department of Psychiatry, 
Benazir Bhutto Hospital, Rawalpindi. 
5 Assistant Professor, Department of Psychiatry, 
HITEC-Institute of Medical Sciences, Taxila. 
6 Professor, Department of Dermatology, 
HITEC-Institute of Medical Sciences, Taxila. 
Author’s Contribution 
1 Conception of study  
1 Experimentation/Study conduction  
2 Analysis/Interpretation/Discussion  
3 Manuscript Writing 
4,6 Critical Review 
5 Facilitation and Material analysis 
Corresponding Author 
Dr. Sundus Fatima, 
Assistant Professor, 
Department of Psychiatry, 




Received:  12/12/2020 
Accepted:  24/09/2021 
 
Cite this Article: Naheed, A., Hayat, A.A., Ain, Q., 
Razzaque, B., Fatima, S., Dar, N. Psychological 
Morbidity in patients with Idiopathic Hirsutism 
presenting for Laser Treatment at a Tertiary Care 
Hospital. Journal of Rawalpindi Medical College. 30 
Sep. 2021; 25(3): 345-350. 
DOI:  https://doi.org/10.37939/jrmc.v25i3.1547 
    Conflict of Interest: Nil 






Objective: The objective of our study was to determine the frequency of depression, anxiety, and stress in females presenting 
for laser treatment of hirsutism at a dermatology clinic.  
Materials and Methods: This was a cross-sectional descriptive study. 152 female participants of all ages presenting for laser 
treatment of hirsutism to the dermatology department –removed for blind review--from June 2019 to Dec 2019, were included 
using a consecutive convenient sampling technique. Patients having an FG (Ferriman and Gallwey) score of 8 or more, were 
included whereas those having any underlying cause (as assessed by history and examination and laboratory investigations 
where required) for both hirsutism and psychological disorder were excluded. The participants were given an Urdu version 
of the DASS 21 (depression, anxiety, and stress scale) to complete. 
Results: The participants had a mean age of 30.22 (SD = 9.17). The prevalence of depression, anxiety, and stress in the sample 
was found to be 13.2%, 23.7%, and 17.8%, respectively. Mean depression, anxiety, and stress scores on DASS 21 were 
4.43(SD=4.87, Cut-off= 10), 4.34(SD=5.12, Cut-off= 8), and 8.21(SD=6.26, Cut-off=15), respectively, indicating that the scores 
were within the normal range. Anxiety was the most common illness in the sample and both depression and stress showed a 
decline with advancing age up till 45years of age. No statistically significant association was found between the severity of 
hirsutism and depression, stress, and anxiety scores. 
Conclusion: Psychological morbidity was found to be lower in patients of idiopathic hirsutism presenting for laser treatment. 
The long-term efficacy of laser treatment needs further evaluation in future research. 
Keywords: hirsutism, psychological morbidity, PCOS, DASS 21, depression, anxiety, stress, Ferriman and Gallwey. 
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Introduction 
 
Hirsutism is defined as the growth of abnormal coarse 
hair in women in male-pattern distribution. There are 
several causes of this hair growth, with the polycystic-
ovarian disease being the commonest. The other 
causes of hirsutism include hormonal imbalances, 
endocrine disorders, drug-induced conditions, and 
idiopathic hirsutism. This abnormal hair growth is 
known to affect self-esteem and the quality of life of 
affected women.1 
As mentioned above, most of the current literature 
evaluating the interplay of hirsutism and 
psychological health comes from patients with 
Polycystic ovarian syndrome. These patients report a 
more inferior quality of life and an increased 
prevalence of depression, which corresponds to the 
severity of hirsutism.2 Data from local studies are 
sparse, but what is available gives us baseline 
information regarding hirsute patients. The most 
common etiology is polycystic ovarian syndrome 
(58%), followed by idiopathic hirsutism (38%) and 
drug-induced hirsutism (4%).3 The psychological 
impact of hirsutism has not been evaluated in any 
local research separately. Some findings are available 
from studies done on patients with Polycystic ovarian 
syndrome. Indian research shows the prevalence of 
depression and anxiety in PCOS patients to be 38.6% 
and 25.7%, respectively, but these were not 
significantly associated with hirsutism; instead, 
lowered Quality of Life scores was associated with 
hirsutism.4 
The various treatments available for hirsutism are both 
pharmacological and non-pharmacological, most 
treatment cycles are 6-months long, and the rate of 
recurrence is high.1 Laser hair removal is a relatively 
new treatment and promises to have a lower 
recurrence rate and fewer side effects, especially for 
patients with idiopathic hirsutism.5 
In the light of current evidence and the fact that laser 
hair removal has only recently become available with 
ease as a treatment option for hirsutism, we aimed to 
understand the impact of hirsutism on the mental 
health of such patients. The objective of our research 
was 1) to determine the frequency of depression, 
anxiety, and stress in women with idiopathic 
hirsutism, and 2) to find if the psychological morbidity 
was associated with the severity of hirsutism. . There is 
minimal data in this regard in patients of idiopathic 
hirsutism6, so we aimed to design our study for these 
women. 
 
Materials and Methods 
 
Ethical approval was obtained from the hospital 
ethical committee for this cross-sectional, descriptive 
study. Patients coming for laser treatment of hirsutism 
to the dermatology department of Heavy industry 
Taxila Education City- Institute of Medical Sciences, 
from June 2019 to Dec 2019, were screened for the 
presence of idiopathic hirsutism by a consultant 
dermatologist.  
The participants who fulfilled the inclusion criteria 
were enrolled in the study using a consecutive 
convenient sampling technique. Written informed 
consent was taken, and 152 participants were included 
in the study. 
Inclusion criteria: Patients presenting at the clinic with 
hirsutism, having a Ferriman and Gallwey hirsutism 
rating scale of 8 or more, and willing to participate in 
the study were included.  
Exclusion criteria: Patients having any underlying 
cause for both hirsutism and psychological disorder 
like polycystic ovarian disease, a psychiatric illness, a 
score of more than 150 on the Holmes and Rahe life 
event scale, or taking an antidepressant, steroid, or 
hormonal treatment were excluded.  
PCOS was diagnosed on history and examination, 
laboratory tests and ultrasound was performed where 
required. PCOS was excluded from the study as laser 
treatment for hirsutism is not the treatment of choice 
in these patients.7 
Ferriman and Gallwey's hirsutism rating scale was 
applied to diagnose and assess the severity of 
hirsutism. Demographic data, along with scores, were 
documented by the dermatologist on a predesigned 
form.  The participants were given an Urdu version of 
the DASS 21 questionnaire to complete in the presence 
of a psychiatrist. 
Data were collected and entered into SPSS 20 for 
analysis. Descriptive statistics were applied. Mean, 
range, and standard deviation was calculated for 
continuous variables like age, FG score, stress, anxiety, 
and depression scores. Frequencies and percentages 
were calculated for discrete variables like age ranges, 
marital status, employment status, the severity of 
hirsutism, stress, anxiety, and depression. A p-value of 
<0.05 was considered significant. 
Data collection tools: 
Ferriman and Gallwey hirsutism rating scale: Ferriman 
and Gallwey hirsutism rating scale system8 is the most 
widely used tool and evaluates body areas for absent-
to-severe hirsutism with scores of 0-4, respectively. 
Overall scores of 8 and higher are consistent with a 
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diagnosis of hirsutism. It is a useful aid in quantifying 
hirsutism as well as evaluating treatment response. 
DASS 21: The 21 item Depression, Anxiety Stress 
Scale9 is a self-report questionnaire used as a 
quantitative measure of distress along the three axes of 
depression, anxiety, and stress reactions and 
management. Twenty-one items need to be scored, 
and it usually takes around 3 to 5 minutes. The 
assessor advises the patient to consider what they have 
experienced in the past week as well as at present and 
to choose the answer that first comes to mind. Each of 
the questions is rated from 0 to 3. Therefore each of the 
axes presents partial scores of 0 to 21 depending on the 
number of items assigned. For analysis, raw DASS 21 
scores were converted to final scores (DASS 42) as per 
manual instructions. Cut-offs for depression, anxiety, 
and stress were taken as 10, 8, and 15, respectively. 
The participants scoring higher than cut-offs were 
booked for detailed assessment and management at 
the psychiatry clinic. 





The total number of participants was 152. All of them 
were females having a mean age of 30.22 (SD = 9.17). 
The youngest participant was 13 years old, while the 
eldest was 52 years. Three-quarters of the sample 
(N=112) were between 15 to 35 years old. 23.7% 
(N=36) were in the age category of 36-45 years, 
whereas only 3 participants were from the 46- 55 age 
category. The characteristics of the participants are 
represented in Table 1. 
The prevalence of depression, anxiety, and stress in 
the sample was found to be 13.2%, 23.7%, and 17.8%, 
respectively. Table 2 shows the distribution of patients 
according to the severity of their Depression, Anxiety, 
and stress scores. 
Mean depression, anxiety, and stress scores were 
4.43(SD=4.87, Cut-off= 10), 4.34(SD=5.12, Cut-off= 8), 
and 8. 21(SD=6.26, Cut-off=15), respectively, 
indicating that the scores were within the normal 
range. (Table 3) 
The youngest age category had only one patient who 
suffered from no psychological symptoms. The eldest 
category had 3 participants so the percentage values in 
that category are 1 out of 3. The middle three age 
categories had sufficient participants and it can be 
seen from Figure 2 that anxiety was the most common 
illness in the sample while both depression and stress 
showed a decline with advancing age up till 45 years 
of age. 
The second main outcome we were looking for in our 
study was the link between the severity of hirsutism 
and depression, anxiety, and stress, to that end we 
found that though the association was not statistically 
significant the prevalence of depression, anxiety, and 
stress were higher in patients with moderate to severe 
hirsutism. (Figure 3) 
We applied the chi-square test and ANOVA to 
determine associations between FG score and 
psychological morbidity as well as with other patient 
characteristics. No statistically significant association 
was found between the severity of hirsutism and 
depression, stress, and anxiety scores. No association 
was found between age, marital status, or employment 
status with the presence of psychiatric morbidity. 
 




MARITAL STATUS 152   
Married 88 57.9%  
Unmarried 63 41.4%  
Separated/ Divorced 1 0.7%  
AGE (years)  30.22 
(SD=9.17) 
Range= 39 
less than 15 1 0.7  
15 to 25 yrs 59 38.8  
26 to 35 yrs 53 34.9  
36 to 45 yrs 36 23.7  




Employed 22 14.5  
Student 40 26.3  
Housewife 82 53.9  
Single and at home 8 5.3  
FG SCORE  13.43 
(SD=3.88) 
Range = 18 
mild  108 71.7  
moderate to severe 44 28.3  
 
Table 2: Prevalence of Depression, Anxiety and 
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Figure 1: Distribution of prevalence of depression, 




Figure 2: Percentage of depression, anxiety, and 
stress in relation to age categories 
 
 





In our study comprising a sample of 152 females, the 
Ferriman and Gallwey hirsutism score was found to be 
of mild intensity in 71.7% of the sample, whereas 28% 
of the study sample had moderate to severe hirsutism 
as demonstrated using the gold standard 
methodology. The prevalence of depression, anxiety, 
and stress in the sample was found to be 13.2%, 23.7% 
& 17.8% respectively, with anxiety accounting for the 
highest prevalence of the 3 disorders. This trend of 
higher anxiety levels is also found in previous studies, 
it is reported that when investigating links between 
psychological impact and symptoms of PCOS, it is 
“hirsutism” that is directly linked to higher anxiety.11 
In Pakistan the anxiety and depressive disorder have 
been exclusively studied in relation to PCOS with 
hirsutism as a symptom. A study showed out of 200 
females, 79.5% had anxiety as compared to 17.5% of 
controls, whereas depressive illness was seen in 50% of 
patients with PCOS as compared to 18% in patients 
without PCOS. 
 The prevalence of psychiatric morbidity in our sample 
is lower as compared to a similar body of work carried 
out in India which showed anxiety and depression of 
38.6% and 27.5%4 respectively in polycystic ovarian 
syndrome. The psychological impact seems 
significantly lesser than other researches and we will 
continue to discuss and address all possible reasons 
for this contrasting variation in the psychiatric 
comorbidity. 
The population in our study consisted of families of 
Heavy industries of Taxila (HIT), comprising those 
entitled to free treatment as well as service provision 
to the general population on out of pocket payment 
basis. The study site was a tertiary care hospital that 
provided quality services at a reasonable cost. 
Although we did not include an inquiry about 
socioeconomic status in our study design since it was a 
relatively homogenous group of patients, most of 
whom were being supported financially because they 
or their family members worked in HIT, it is safe to 
assume that they belonged to at least middle 
socioeconomic class. Psychological illness especially 
depression is noted to be less common in women 
coming from financially sound households as depicted 
by a recent investigation into socio-economic factors 
linked to depression in women living in Northern 
Pakistan.12 This may be one of the reasons for lower 
than average rates of depression, anxiety, and stress in 
our sample. 
In the Pakistani population factors positively 
associated with anxiety and depressive disorders in 
various psychiatric studies have been female sex, 
middle age, low level of education, financial difficulty, 
being a housewife, and relationship problems. The 
mean age of depressed patients in studies is 36.8 
years13, and in other studies to be 34.31 years. In the 
study by Mirza and Jenkins14 association with 
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depression was found to be significant in middle age 
and onwards. Moreover, this systematic review 
suggests an overall mean prevalence of 33% for 
depression in the Pakistani population.14 Most of our 
sample was young and only 3 patients were above the 
age of 45 years, this may also be contributing to low 
levels of reported depression.     
Although rates of depression are reported high in 
studies from Pakistan, results similar to our study 
have also been reported in a study on younger single 
females carried out in rural Pakistan15, which 
demonstrated that depressive disorder was not 
commonly prevalent in young single women in rural 
Pakistan. In this study of a sample size of 321, aged 16-
18 single women in rural Pakistan, only 14 (4.4%) had 
a depressive disorder. In our study 41.4%, women 
were single and 57.9% were married. Age-wise the 
largest subset in the age group (38.8%) belonged to 15 
to 25 years of age.  Although most studies from 
Pakistan report higher rates of depressive illness but 
similar to our sample very low results of depressive 
illness have been reported in younger females in the 
country.  
It seems almost perceptive to associate hirsutism with 
a detrimental impact on psychological well-being, 
poorer quality of life, and stress. Most literature on 
hirsutism and the psychological impact that ensues has 
been carried out with an exclusive focus on PolyCystic 
Ovarian Syndrome (PCOS). In addition to the 
symptom of hirsutism, PCOS has other accompanying 
symptoms like infertility and obesity, all of which are 
known to cause a huge impact on the health of the 
women resulting in higher levels of depression and 
anxiety, greater dissatisfaction with themselves, and 
feeling of being less feminine due to excessive facial 
hair growth, as compared to women without having 
PCOS.16 Idiopathic hirsutism, on the other hand, is not 
associated with these additional symptoms and 
accompanying hormonal imbalances, these reasons 
can therefore be a possible explanation for lower 
psychiatric morbidity in our study compared to the 
higher psychiatric morbidity seen in most other 
hirsutism researches with a focus on PCOS.  
Most of the previous research on hirsutism has 
demonstrated that the higher the degree of hirsutism, 
the more profound is the psychological impact 
experienced by the individual suffering from the 
condition.17 Many of the pre-existing researches 
deployed the Ferriman and Gallwey hirsutism 
rating/scoring system, which can be administered 
either through self-rating by the patients themselves, 
or rated by the clinician. The preexisting work of 
research has extensively used self-report scoring, a 
methodology that has demonstrated previously in 
research that patients tend to over-report the 
magnitude of hirsutism when self-reporting on the 
Ferriman and Gallwey hirsutism scoring system.2 It is 
for that reason the overall calculation of hirsutism 
assessment and documentation has generated varying 
results. One possible reason for less prevalence of 
psychiatric morbidity contrasting similar bodies of 
work carried out elsewhere that showed higher 
psychiatric comorbidity can be attributed to milder 
hirsutism FG score in our study. A significant aspect 
worth addressing here is that in our study the FG 
rating was done by a trained and an expert clinician 
rather than deploying the self-report methodology. 
Data from researches have proven that with self-report 
measures done by patients, they are more likely to 
view their hirsutism as more severe than clinicians. It 
is most likely for this reason that the FG scores in this 
study have shown a milder hirsutism score in the 
71.7% study population and as expected from 
previous data sets have shown lower psychiatric 
morbidity.  
Our study addressed the issue of idiopathic hirsutism, 
the diagnosis of which is made after ruling out many 
physical causes like hormonal changes, physical and 
medical comorbidities. Idiopathic hirsutism is known 
to have a good prognostic outcome with laser 
treatment. One possible reason for lower psychiatric 
morbidity in our study population was seeking 
treatment knowing the prognostic implications and 
that the treatment will produce the desired results, 




It is a cross-sectional study and done in a single 





This study provides an insight into the psychological 
impact of idiopathic hirsutism, a relatively untouched 
research area. It also provides a snapshot of the mental 
state of a patient population about to receive a 
promising treatment. We have found that having an 
assurance of effective treatment and the ability to 
afford it may result in lower levels of psychological ill-
health despite suffering from a stigmatizing condition. 
Hence, it may not be prudent to do routine screening 
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of psychological morbidity for these patients. It will be 
worthwhile to look into the long-term efficacy of laser 
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